65,437 trials
Chronic Obstructive Pulmonary Disease
Primary: To Evaluate the Rate of Severe Exacerbations in COPD, Comparing COPD Patients Previously Treated According to the PRO-CT Protocol Versus COPD Patients Previously Treated…
Kidney Stone
Primary: Time of Stone Passage — 68.8; 19.0 hours
Bipolar I Disorder · Schizophrenia
Primary: Mean Change From Baseline to 52 Weeks in Body Mass Index (BMI) for All Participants — 3.64; 2.83 kilograms per meter squared (kg/m^2) — p=0.150
Healthy
Primary: DOBmax (Maximum Value of DOB) — 4.44; 3.49; 0.92 ratio
Pre-hypertension
Primary: Change in Disease Score (DS) Among the Treatment Groups — -2.48; -2.29; -2.38; -0.96 Overall Rasmussen Disease Score Change
Mycoses · Fungemia · Central Nervous System Fungal Infections
Primary: Frequency of Fungal Infection — 5; 8 participants
Cocaine Dependence
Primary: Maximum Days of Continuous Cocaine Abstinence — 42.9; 46.6 Days
Depression
Primary: Time to Remission — 13.67; 11.33 weeks
Persian Gulf Syndrome
Primary: The Short-form McGill Pain Questionnaire — 54.0; 65.5 units on a scale
Hypercholesterolemia
Primary: Change in Glycated Hemoglobin (HbA1c) From Baseline — 0.22; 0.14 Percent
Healthy Volunteers
Primary: Changes in Airway Blood Flow After 180μg Albuterol by Inhalation (ΔQaw) vs Baseline — 16.8; 14.5; -0.2; 2.0 changes from baseline in μl.min-1.ml-1
Postoperative Pain
Primary: Postoperative Pain Score on Coughing at 6 hr — 5.28; 3.59 units on a scale
Vitamin B6 Deficiency
Primary: Total Remethylation of Homocysteine — 6.07; 5.63 micromol/(kg x hr) — p=0.20
Wrinkles
Primary: Efficacy — 77; 74; 73; 72 participantes rated improved and higher
Urticaria · Angioedema · Hives
Primary: Medication Usage — 2.8; 4.6; 2.0; 4.9 number of pills/day